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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial infections worldwide. To differentiate reliably among
S. aureus isolates, we recently developed double locus sequence typing (DLST) based on the analysis of partial sequences of clfB and spa
genes. In the present study, we evaluated the usefulness of DLST for epidemiological investigations of MRSA by routinely typing 1242
strains isolated in Western Switzerland. Additionally, particular local and international collections were typed by pulsed ﬁeld gel electro-
phoresis (PFGE) and DLST to check the compatibility of DLST with the results obtained by PFGE, and for international comparisons.
Using DLST, we identiﬁed the major MRSA clones of Western Switzerland, and demonstrated the close relationship between local and
international clones. The congruence of 88% between the major PFGE and DLST clones indicated that our results obtained by DLST
were compatible with earlier results obtained by PFGE. DLST could thus easily be incorporated in a routine surveillance procedure. In
addition, the unambiguous deﬁnition of DLST types makes this method more suitable than PFGE for long-term epidemiological surveil-
lance. Finally, the comparison of the results obtained by DLST, multilocus sequence typing, PFGE, Staphylococcal cassette chromosome
mec typing and the detection of Panton-Valentine leukocidin genes indicated that no typing scheme should be used on its own. It is only
the combination of data from different methods that gives the best chance of describing precisely the epidemiology and phylogeny of
MRSA.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has
become a major cause of nosocomial infections worldwide.
Studies have shown that when a high proportion of MRSA
has been encountered among S. aureus, one or few clones
have been predominant [1]. Analysis of more than 3000 iso-
lates from different countries demonstrated the existence of
ﬁve major pandemic clones [1]. However, recent data have
indicated that the geographical spread of MRSA over long
distances is a rare event compared to the frequency with
which the staphylococcal cassette chromosome mec (SCCmec)
island has been acquired [2]. In addition, new strains that
disseminate in the community [3] or in animals have recently
emerged [4]. These strains have frequently been associated
with speciﬁc biological characteristics (e.g. reduced suscepti-
bility to antibiotics, enhanced virulence). These observations
emphasize the importance of the surveillance of MRSA
clones at regional and international levels.
During the last decade, the epidemiology of MRSA has
mainly been analysed by pulsed ﬁeld gel electrophoresis
(PFGE). However, this method suffers from poor inter-labo-
ratory standardization and from potentially ambiguous
results, especially when large number of isolates are analy-
sed. In this context, several DNA-based sequence methods
such as multilocus sequence typing (MLST) [5] and spa-typing
[6] have been developed for the epidemiological identiﬁca-
tion and differentiation of S. aureus strains. Recently, we have
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developed the double-locus sequence typing (DLST) method
based on the analysis of approximately 500 bp of the highly
variable clfB and spa genes [7]. This method gives more types
and is far more discriminatory than spa-typing, matches the
high resolution of PFGE and shows good congruence with
the results obtained by MLST [7–9]. The combination of high
typeability and reproducibility with low cost, ease of use and
unambiguous deﬁnition of types makes this method especially
useful for epidemiological analyses.
In the present study, we used DLST, SCCmec typing, and
Panton-Valentine leukocidin (PVL) detection to analyse 1242
strains isolated in Western Switzerland, as well as a panel of
strains representing major Swiss and international clones. The
study aims were: (i) to evaluate the usefulness of DLST in
investigation of the molecular epidemiology of MRSA at a
regional level; (ii) to check whether the results obtained by
DLST were compatible with earlier results obtained by PFGE;
and (iii) to check whether the results obtained by DLST
enabled a comparison with international predominant clones.
Materials and methods
Setting
Medical laboratories and infection control programmes in
the canton of Vaud, Switzerland, refer all MRSA isolates
(from infected or colonized in- or outpatients) to our refer-
ence laboratory (University Hospital of Lausanne).
Isolates
All isolates recovered between January 2005 and December
2007 and sent to the reference laboratory were re-identiﬁed
at the species level and checked for methicilin-resistance [disc
diffusion antibiogram with oxacillin and/or agglutination test
for detection of the PBP2¢ protein (Slidex MRSA detection;
bioMe´rieux, Marcy l’Etoile, France)]. In addition, antibiograms
were performed using the disc diffusion method. One isolate
per patient and per year was saved by the reference labora-
tory. If a change in the antibiogram was observed, the new
phenotype was also saved. For each patient, demographic data
were collected (name, age and sex), as well as the date and site
of MRSA isolation. Isolates were stored and further processed
in 96-well plates, thus reducing cost and working time.
Double locus sequence typing
DLST was performed according to a previously described
method [7]. For each gene, an arbitrary number was given to
each allele, and the combination of both clfB and spa alleles
constituted the DLST type. It is important to note that
although spa-typing and DLST investigate polymorphisms in
the spa gene, both methods do not analyse the same regions
of the gene. Therefore, the spa-alleles of these two methods
are not identical. Although the comparison between DLST and
spa-typing was outside the scope of the present study, the cor-
respondence between spa-typing and DLST-spa alleles is given
in the Supporting Information for comparison purposes.
SCCmec typing and detection of PVL encoding genes
SCCmec was typed according to the scheme of Kondo et al.
[10]. PVL encoding genes lukS-PV and lukF-PV were co-ampliﬁed
by PCR reactions, as previously described [11], with primers
luk-PV-1 and luk-PV-2. The same extracted DNA was used for
DLST typing and for SCCmec typing and PVL detection.
Clone deﬁnition
Whereas the DLST markers appear to be highly stable during
local epidemiological investigations [7], they might undergo
changes over a long period. Therefore, we also considered
related genotypes in our deﬁnition of clones. Because the
reconstruction of genetic relatedness is highly problematic
with sequences containing repeats, we used an approach sim-
ilar to the analysis of MLST data with the BURST (Based Upon
Related Sequence Type) algorithm. We considered only alle-
lic data and the relatedness was deﬁned by clustering all
DLST types sharing one of the two alleles (single locus vari-
ant, SLV). With this approach, a clone was deﬁned by the
cluster of SLV DLST types and its founder. This analysis was
performed using EBURST (http://eburst.mlst.net/).
Comparison between the results obtained by DLST and
PFGE
To assess the congruence between PFGE (used in our
laboratory until 2005) and DLST, we analysed two datasets
with both methods: (i) a retrospective selection of 189
isolates representing the major local PFGE clones isolated
between 1997 and 2004 and (ii) the ﬁrst 150 consecutive
isolates of 2005.
Relatedness to international clones
A collection of 74 strains representing the major Swiss and
international clones was analysed with DLST, MLST, SCCmec
typing and the detection of PVL genes. MLST was performed
as described previously [5].
Results
Local DLST analysis
In total, 1242 isolates (one per patient and per year) were
recovered in the Vaud Canton of Switzerland between
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January 2005 and December 2007. Among these isolates,
187 DLST genotypes were observed. The spa sequence of
two isolates (0.16%) was not obtained despite repeated test-
ing; therefore, a null allele (0) was considered for these sam-
ples. The majority of isolates (72%) belonged to the three
predominant DLST genotypes 2-2 (n = 693; 56%), 3-3
(n = 111; 8.9%), and 4-4 (n = 91; 7.3%).
Cluster analysis of the 1242 isolates highlighted the three
main clones corresponding to the predominant genotypes
(i.e. DLST 2-2, 3-3, 4-4) and their single locus variants
(Fig. 1). In addition, 14 smaller clusters, composed of 2-12
DLST types, and 22 isolated DLST types were observed.
Analysis of SCCmec and PVL detection
The analysis of the SCCmec type in the 1242 isolates showed
the presence of the six main types (Table 1). We were
unable to determine the SCCmec type of 36 isolates (2.9%)
with the Kondo scheme. Most isolates within a predominant
cluster harboured an identical SCCmec type.
A total of 65 isolates (5.2%) were PVL-positive (Fig. 1).
These isolates belonged to 20 DLST genotypes. Most isolates
of the three predominant clusters did not harbour the PVL
genes.
Comparison between DLST and PFGE
Among the 339 isolates typed by both PFGE and DLST, 267
isolates were classiﬁed by PFGE into four major clones (i.e.
A, B, C and D) previously identiﬁed in Western Switzerland
(a PFGE clone being deﬁned as all isolates with less than
seven band differences in their PFGE pattern). Congruence
between PFGE and DLST was evaluated for each major clone
by calculating the percentage of isolates belonging to the
corresponding DLST clones (i.e. DLST cluster 1-1, 2-2, 3-3
and 4-4). This analysis showed a congruence of 88% between
the two methods (Table 2). Interestingly, the congruence
between these typing methods decreases with the age of the
clone.
Comparison with international MRSA clones
Typing of isolates representing major Swiss and international
clones with both MLST and DLST showed the usefulness of
DLST in relating the local epidemiology to the international
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FIG. 1. Double locus sequence typing (DLST) single locus variant (SLV) clustering using eBurst on the 1242 MRSA isolates recovered in the
Vaud canton (Switzerland) between 2005 and 2007. Each circle represents one DLST-type and the diameter of the circles reﬂects the frequency
of that type (i.e. the number of isolates). Linked DLST-type differ at one of the two loci (clfB or spa). For each cluster, the founder and sub-foun-
der are indicated in blue and yellow, respectively. DLST and staphylococcal cassette chromosome mec (SCCmec) types of each founder and sub-
founder are indicated in bold. For each SLV, SCCmec is only indicated (in green) when it differs from the founder. Unidentiﬁed SCCmec types are
indicated by the letter N. DLST types carrying PVL-positive isolates are indicated by red plus (+) signs. Signs in parentheses indicate that not all
the strains of that DLST-type have this characteristic.
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situation (Table 3). Strains that showed the clfB allele 1
(Swiss clone A, clone 2 from Belgium, and a Finnish clone)
were most likely all related to the Berliner clone (ST45-IV).
The Swiss clone DLST 2-2 showed the same DLST alleles
and SCCmec type as the Japan clone (strain MU50 and
N315), although they belonged to different but closely-
related sequence types (STs) (105 and 5, respectively). The
Swiss clone DLST 3-3 was identical to the French Lyon
clone, suggesting a dissemination from France to Switzerland.
However, the CA-MRSA USA 300 clone also showed the
same DLST alleles and SCCmec type. Nevertheless, this clone
is characterized by the presence of the PVL genes.
Discussion
Our characterization of MRSA isolates with a sequence-
based method that analyses the two highly variable clfB and
spa genes (DLST) showed the value of this method for
regional surveillance. We were able to identify the main
clones present in the region, and the typing of international
clones revealed close relationships between several local and
international clones. Moreover, the congruence of 88%
between the major PFGE and DLST clones indicates that the
results obtained by DLST were compatible with earlier
results obtained by PFGE [12]. The major advantage of DLST
over PFGE is the unambiguous deﬁnition of types allowing
inter-laboratory comparisons and reproducibility. Performing
DLST typing in batches of 96 isolates was easily incorporated
into our regional surveillance procedure, thus reducing cost
and working time, in comparison with PFGE [7].
Cluster analysis of DLST data
For surveillance of MRSA clones, it is necessary to use typing
methods that unambiguously cluster closely related geno-
types. Analysis of clfB and spa sequences with phylogenetic
tools could not be performed because the region analysed in
these genes comprises repeats. However, using the eBURST
algorithm to cluster DLST data, we were able to identify
three major clusters (i.e. DLST 2-2, 3-3 and 4-4) that had
already been recognized by PFGE [12]. It should be noted
that SLV analysis of DLST data should not be considered as
a phylogenetic representation of the species. Horizontal
transfer of the spa and clfB alleles occurs at low frequency
among clonal complexes [9] and the information contained
in only two fast evolving loci is insufﬁcient for that purpose.
Interestingly, the two main clones that recently emerged and
disseminated in the area (i.e. DLST clusters 2-2 and 4-4)
were characterized by a high frequency of the founder
DLST-type, and by SLV present in only one or a few
patients. This most likely illustrates the evolution and dissem-
ination of the founder DLST-type, and the occurrence of
mutations over time in this founder. By contrast, the older
epidemic clone, which was no longer predominant at the
time of the study (DLST cluster 1-1, which emerged in
1995), was characterized by only few isolates belonging to
the founding DLST type. This most likely indicates the fading
of this clone. BURST analysis of DLST can thus reveal the
waxing and waning of MRSA clones at a local level.
Molecular epidemiological surveillance of MRSA
The European Study Group on Epidemiological Markers
(ESGEM) recently emphasized that a clone is the grouping of
isolates sharing not only genetic characteristics, but also bio-
logical characteristics [13]. These biological elements such as
virulence, pathogenicity and antibiotic resistance often have
genetic determinants (e.g. SCCmec, PVL and other virulence
genes) that are located on mobile elements, and their acqui-
sition constitutes a major change for epidemiological surveil-
lance. These observations indicate that no typing scheme
should be used on its own. The combination of data from
several typing methods, as well as the investigation of resis-
tance/virulence determinants, would give the best chance of
TABLE 1. Staphylococcal cassette chromosome mec (SCC-
mec) types observed among all strains and in the three
major clones
I II IIImercury IV V VI na Total
Cluster 2-2 8 768 0 8 9 1 1 797
Cluster 3-3 1 2 0 127 0 2 15 147
Cluster 4-4 126 0 0 0 1 0 8 135
All 135 776 17 248 27 3 36 1242
aUnidentiﬁed SCCmec types
TABLE 2. Congruence between
isolates belonging to pulsed ﬁeld
gel electrophoresis (PFGE) clones
A, B, C, and D, and corresponding
double locus sequence typing
(DLST) clones 1-1, 2-2, 3-3, 4-4
PFGE/DLST
clone
Year of emergence
of the clone in
the region
No of isolates
belonging to the
PFGE clone
No of isolates
belonging to the
corresponding
DLST clone
Congruence
(%)
A/1-1 1995 41 30 73
B/2-2 1998 109 104 95
C/3-3 Endemic 86 70 81
D/4-4 2000 31 31 100
Total 267 235 88
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describing the true time and space distribution of MRSA
genotypes in the population. This is illustrated in our region
by the situation of the Swiss clone C [12]. This clone was
deﬁned according to largely accepted interpretation criteria
for PFGE patterns [14], and all its proﬁles were considered
to be related (i.e. no more than six band differences) when
taken one by one. However, no predominant PFGE proﬁle
was observed during 8 years of surveillance, and we hypoth-
esized that most of the patients harbouring this clone were
transferred from foreign hospitals [12]. Consequently, we
retrospectively typed representative isolates of this clone as
well as some isolates of international clones with PFGE,
DLST, SCCmec and PVL detection (Fig. 2). This analysis
revealed that the Swiss clone C was composed of at least
ﬁve clones: the Brazilian clone (ST239-SCCmec IIImercury,
DLST cluster 29-30, PVL negative); the Iberian clone (ST
247-SCCmec I, DLST cluster 8-5, PVL negative); the Lyon
clone (ST8-SCCmec IV, DLST cluster 3-3, PVL negative); the
USA300 clone (ST8-SCCmec IV, DLST cluster 3-3, PVL posi-
tive); and a cluster of strains that were differentiated by
PFGE only (ST 8-SCCmec IV, DLST 3-3, PVL variable).
Although there was a good correspondence among the
TABLE 3. Multilocus sequence typing (MLST), double locus sequence typing (DLST), staphylococcal cassette chromosome mec
(SCCmec) types and the presence of PVL genes in a selection of strains representing major Swiss and international methicillin-
resistant Staphylococcus aureus clones
CCa STb DLST type
SCCmec
type
No of PVL
isolates
Year of
isolation Origin Clone/strain References
1 1 5-254 IV neg 1 1998 USA Strain MW2
5 83 37-15 I neg 1 1992 Poland Polish clone A4 [17,18]
5 105 2-2 II neg 1 1998 Switzerland Swiss clone B [12]
5 5 2-2 II neg 1 1982 Japan Strain N315
5 5 2-2 II neg 1 1996 Japan Strain MU50
5 5 19-2 I neg 1 1994 France
5 5 19-23 N neg 1 1995 Belgium
5 5 4-274 I neg 1 1990 France
5 125 4-36 IV neg 1 2001 Finland
5 228 4-4 I neg 1 2001 Switzerland Swiss clone D [12]
5 228 4-16 I neg 1 1995 Germany South German clone [19]
5 228 4-16 I neg 1 1995 Belgium
8 8 3-3 IV neg 1 1999 Belgium
8 8 3-3 IV neg 6 1992 France Lyon clone [20]
8 8 3-3 IV neg 2 2002 The Netherlands
8 8 3-3 IV neg 1 2004 Switzerland Swiss clone C
8 8 3-3 IV pos 9 2003 USA USA 300 [21]
8 8 3-34 IV pos 1 2003 USA USA 300 [21]
8 8 3-96 IV pos 1 USA USA 300 [21]
8 239 369-30 III neg 1 1992 Poland Clone B16 [17,18]
8 239 29-30 IIImerc neg 2 1995 Portugal Brazilian clone [22]
8 239 36-30 IIImerc neg 1 1994 Portugal Brazilian clone [23]
8 239 243-30 IIImerc neg 1 2002 The Netherlands
8 New 29-30 IIImerc neg 1 1993 Austria Phage groupe III [19]
8 247 8-3 I neg 2 1992 Portugal Iberian clone [24]
8 247 8-5 I neg 1 1995 Germany North German clone [19]
8 247 8-5 I neg 1 1995 Belgium
8 247 8-5 I neg 3 1992 Portugal Iberian clone [23]
8 247 8-18 I neg 2 1993 Belgium Belgium clone 3 [25]
8 247 8-19 N neg 1 1993 Belgium Belgium clone 1 [25]
8 247 9-33 I neg 1 1990 France
8 250 9-3 I neg 1 1960 England Strain COL
8 254 9-9 N neg 1 1993 Germany Phage groupe III [19]
8 1014 3-35 IV neg 1 1999 Finland Kokkola clone
22 22 32-24 IV neg 1 2001 Portugal EMRSA-15 [26]
22 22 32-40 IV neg 1 England EMRSA-15
22 79 33-24 N neg 1 2000 Portugal EMRSA-15 [26]
30 36 27-22 II neg 1 1993 England EMRSA 16 [27]
45 45 1-1 IV neg 1 1995 Switzerland Swiss clone A [12]
45 45 1-1 IV neg 1 1993 Belgium Belgium clone 2 [25]
45 45 1-10 IV neg 1 1993 Germany Phage pattern 95 [19]
45 45 1-11 IV neg 1 1996 Germany Berlin clone [19]
45 45 1-13 V neg 3 2001–2002 The Netherlands [28]
45 45 1-37 IV neg 1 1996 Finland
45 45 34-13 V neg 1 2001 The Netherlands [28]
45 45 300-10 N1 neg 1 1997 Switzerland Drug user clone [29]
45 455 22-11 II neg 2 2003 Norway Norwegian clone A [30]
45 497 24-12 IV neg 1 2003 Norway Norwegian clone B [30]
45 New 23-10 II neg 1 1996 Canada OE-MRSA [31]
80 80 46-26 IV pos 1 2001 Switzerland European CA-MRSA [12]
– 152 48-43 V pos 1 1999 Switzerland Balkan clone [12]
aMLST clonal complexe
bMLST sequence type
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FIG. 2. Similarities of pulsed ﬁeld gel electrophoresis (PFGE) restriction patterns of some representative strains of the Swiss clone C. Double
locus sequence typing (DLST) type, spa type, sequence type (ST), clonal complex (CC), staphylococcal cassette chromosome mec (SCCmec) type,
and presence of PVL genes were also indicated when available. Similarities between strains were calculated with the Dice coefﬁcient and a band
position tolerance of 1.5% (deﬁned as the lowest tolerance that enable 100% similarity between patterns of a control strain included in each
gel). The dendrogram was constructed using the unweighted pair group method with arithmetic mean algorithm.
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typing results, none of the methods alone was powerful
enough to identify each clone. Interestingly, the difﬁculty of
discriminating among the strains belonging to ST8 was the
same with DLST and with spa-typing. This indicates that the
combination of PFGE/DLST with SCCmec typing and PVL
detection is sometimes necessary to obtain a clear under-
standing of the local epidemiology of MRSA.
The use of typing methods with high discriminatory power
is required for epidemiological investigations, especially in
local (e.g. hospital) studies. However, despite the genetic
diversity of S. aureus, the existence of successful genotypes
reduce the efﬁciency of molecular typing for local investiga-
tion. For example, 60–80% of MRSA isolates are indistin-
guishable by PFGE in most UK hospitals since they belong to
the two predominant strains EMRSA-15 and -16. We
observed a predominance of some speciﬁc genotypes,
although we analysed the sequence of the most variable
genes in S. aureus. This further highlights the need to combine
typing methods.
Presence of PVL genes and other mobile elements
The presence of PVL is often associated with community-
acquired MRSA (CA-MRSA). In the present study, 65/1242
(5.2%) isolates showed the presence of this pathogenic fac-
tor. Two DLST clusters were composed of PVL-positive iso-
lates only and probably represent CA-MRSA clones, although
we did not have epidemiological data to conﬁrm the origin
of these MRSA. The ﬁrst cluster had the DLST founder
46-26-IV and was identiﬁed in 19 patients during the 3 years
of the study. This cluster belonged to ST80, which is known
as the European CA-MRSA clone [15]. The second cluster
had the DLST founder 48-43-V and was identiﬁed in only
eight patients. This cluster belonged to ST152 which was
mainly isolated from patients of Balkan origin and is a MRSA
clone from central Europe [12].
Interestingly, among the 80 isolates with the DLST geno-
type 3-3 and SCCmec type IV, 18 were PVL positive (Fig. 1).
This DLST genotype is identical to both the USA 300 clone
and the French Lyon clone. These two clones differ in their
PFGE patterns and in the presence of the PVL genes in the
USA 300 clone. PFGE typing of some PVL-positive isolates
indicated that they probably belonged to the clone USA 300.
However, PVL genes are located on mobile genetic elements,
which might also have been acquired by strains of the Lyon
clone. Therefore, it is necessary to study other characteris-
tics of that clone (such as the presence of the arginine cata-
bolic mobile element) [16] to conﬁrm that all PVL-positive
DLST 3-3 SCCmec IV strains belonged to the USA 300 clone.
In conclusion, our DLST analysis of MRSA isolated in a
region of Switzerland showed that this method gives results
comparable with those obtained by PFGE. In addition, the
unambiguous typing results with DLST make this method
much more suitable than PFGE for long-term epidemiological
surveillance. Analysing a selection of international clones
allowed international comparisons. The combination of
results from DLST, SCCmec and PVL proved to be a useful
approach for the unambiguous demonstration of the emer-
gence of new clones. Finally, it is important to note that no
typing scheme should be used on its own. Dynamic and
open-source databases should be established to combine
data from clinical epidemiology with data from several
different sequence typing methods and of resistance/virulence
determinants. This would provide the most precise
description possible of the epidemiology and phylogeny of
MRSA.
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